Cargando…
Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
Multiple drug resistance remains an unsolved problem in cancer therapy. A previous study has demonstrated that the chemotherapeutic drug doxorubicin (Dox) induced upregulation of P-glycoprotein in endothelial cells, resulting in a 20-fold increase in drug resistance and reduced efficiency of doxorub...
Autores principales: | HUANG, LIMIN, HU, CHAOQUAN, DI BENEDETTO, MÉLANIE, VARIN, RÉMI, LIU, JIELIN, JIN, JIAN, WANG, LI, VANNIER, JEAN-PIERRE, JANIN, ANNE, LU, HE, LI, HONG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315062/ https://www.ncbi.nlm.nih.gov/pubmed/25663899 http://dx.doi.org/10.3892/ol.2014.2819 |
Ejemplares similares
-
Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib
por: Huang, Limin, et al.
Publicado: (2014) -
Drug resistance-related sunitinib sequestration in autophagolysosomes of endothelial cells
por: Wu, Shuang, et al.
Publicado: (2019) -
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
por: Huang, Limin, et al.
Publicado: (2013) -
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018) -
Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)